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R
andomized clinical trials
(RCTs) represent the best
study design for minimizing
bias when investigating the effective-
ness of a form of treatment. RCTs also
are the building blocks of systematic
reviews and meta-analyses, which
allow more generalizable conclusions
to be drawn about therapeutic efficacy
[1], provided that the trials themselves
are well-designed and implemented,
and provided that all of the data are
available for such analyses.
Unfortunately, meta-analyses can
only include those data that the authors
can find. Many prospective trials are
started but never finished, and many
more are completed but never pub-
lished [2–5]. The RCTs that are
published therefore only represent a
proportion of those that are under-
taken, and there is compelling
evidence that if a study has a positive
outcome it is more likely to be pub-
lished [6].
Selective publication of this sort,
sometimes called publication bias or
positive-outcome bias, is harmful for
at least two reasons. First, if two
studies—one showing positive results
and one showing no difference
between interventions—have been
performed, and the study with the
positive outcome is more likely to be
published and therefore available for
meta-analysis, meta-analyses will tend
to inflate the apparent benefits of a
treatment and de-emphasize its harms
[7, 8]. This may lead to the inappro-
priate adoption of new interventions
that are less effective than they seem
and that almost always are more
expensive. Second, when studies that
record no difference between inter-
ventions are performed but not
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published, a wasteful duplication of
resources is likely to ensue when
clinicians subsequently conduct trials
that unbeknownst to them have already
been carried out.
A solution to this problem has
existed for some time. RCTs should be
registered in one of the numerous
publicly available, free, searchable,
well-maintained repositories of clinical
trials before the first patient is enrolled
[9–11]. In addition to mitigating posi-
tive-outcome bias and reducing the
likelihood that expensive, time-con-
suming trials will needlessly and
unknowingly be repeated, prospective
registration helps journals to minimize
data dredging by allowing verification
that the end points reported were the
end points initially proposed by the
researchers [12]. Prospective registra-
tion also allows patients to identify
trials in which they may wish to enroll,
and it can help institutional review
boards find research germane to the
studies that they evaluate [13].
For several years, The Journal of
Bone and Joint Surgery, The Bone &
Joint Journal, and Clinical Orthopae-
dics and Related Research1 have
either required or encouraged trials to
be registered but permitted it to be
done retrospectively (that is, after the
study had been completed). We now
all concur that this is not sufficient.
Retrospective registration merely to
allow a paper to be considered for
publication by a journal does not allow
the identification of no-difference
findings, minimize data dredging, help
patients find care, or support ethics
panels in their important work. The
International Committee of Medical
Journal Editors (ICMJE) has required
that its member journals insist on
prospective registration for more than
a decade now [14]. It is time for the
leading journals of orthopaedic surgery
to do likewise.
With that in mind, as of now, The
Journal of Bone and Joint Surgery,
The Bone & Joint Journal, and
CORR1 require registration in a pub-
licly searchable clinical trials registry
prior to the publication of RCTs, and
the registry number of the trial will be
published in the electronic and print
versions of these papers. Until the end
of 2017, which we consider a transi-
tion period, this registration may take
place either prospectively or retro-
spectively; but as of January 1, 2018,
authors of all RCTs that began after
the publication of this editorial must
demonstrate proof of prospective reg-
istration to be considered for review by
any of our three journals.
We understand that there will be
rare situations in which prospective
registration is not possible or not
appropriate, and we will be receptive
to such claims. In these situations, the
authors will be expected to explain in
the limitations section of the paper the
reasons for non-registration, and the
editors will add a note to the title page
of such a paper explaining why the
exception was permitted. However,
simple omission of prospective regis-
tration will not be considered a
suitable excuse; the principles at stake
here are too important.
We encourage all orthopaedic jour-
nals to join us in setting and
maintaining this important principle
underlying the reporting of research in
our specialty.
Acknowledgment The authors would like
to acknowledge for their contributions to this
important policy and the editorial that artic-
ulated it the Senior Editors of Clinical
Orthopaedics and Related Research (Mat-
thew B. Dobbs MD; Mark C. Gebhardt MD;
Terence J. Gioe MD; Paul A. Manner MD,
FRCSC; Raphae¨l Porcher PhD; Clare M.
Rimnac PhD; and Montri D. Wongworawat
MD) as well as its Managing Director (Lee
Beadling BA); the Editorial Board of The
Journal of Bone and Joint Surgery (Jean-Noe¨l
A. Argenson MD, PhD; Thomas W. Bauer
MD, PhD; Thomas D. Brown PhD; Charles R.
Clark MD; Charles M. Court-Brown MD,
FRCSCEd[Orth]; Lars Engebretsen MD,
PhD; Andrew Green MD; Anil K. Jain MS,
FAMS, FRCS; Michelle A. James MD;
Bernhard Jost MD; Jeffrey N. Katz MD, MSc;
Eng Hin Lee MD, FRCSC; Elena Losina
PhD; Stephen Lyman PhD; Konstantinos N.
Malizos MD, PhD; Robert G. Marx MD,
MSc, FRCSC; Sanjeev Sabharwal MD, MPH;
Bruce Sangeorzan MD; Christoph J. Siepe
MD; Paul D. Sponseller MD; Stephen R.
Thompson MD, MEd, FRCSC; Daisuke
Togawa MD, PhD; and James P. Waddell
MD, FRCSC) and its Editors Emeritus
123
2 Leopold et al. Clinical Orthopaedics and Related Research1
Editorial
(Vernon T. Tolo MD, and James D. Heckman
MD); and the Editorial Board of The Bone &
Joint Journal (Matthew Costa PhD,
FRCS[Tr&Orth]; Richard Carey Smith
BSc[Hons], MB, BS, MRCS, FRCS[Orth],
FAOrthA; Melina Dritsaki BSc, MSc, PhD;
Xavier Griffin FRCS[Tr&Orth], PhD;
Nicholas Parsons BSc, MSc, PhD; Daniel
Perry FRCS[Orth], PhD; and Dirk Stengel
MD, PhD, MSc).
Open Access This article is distributed
under the terms of the Creative Commons
Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which
permits unrestricted use, distribution, and
reproduction in any medium, provided you
give appropriate credit to the original
author(s) and the source, provide a link to the
Creative Commons license, and indicate if
changes were made.
References
1. Howick J, Chalmers I, Glasziou P,
Greenhalgh T, Heneghan C, Liberati
A, Moschetti I, Phillips B, Thornton





Accessed 2016 June 21.
2. Bekelman JE, Li Y, Gross CP. Scope
and impact of financial conflicts of
interest in biomedical research: a
systematic review. JAMA. 2003;289:
454–465.
3. Emerson GB, Warme WJ, Wolf FM,
Heckman JD, Brand RA, Leopold
SS. Testing for the presence of pos-
itive-outcome bias in peer review: A
randomized controlled trial. Arch
Intern Med. 2010;170:1934–1939.
4. Lie`vre M, Me´nard J, Bruckert E,
Cogneau J, Delahaye F, Giral P,
Leitersdorf E, Luc G, Masana L,
Moulin P, Passa P, Pouchain D, Siest
G. Premature discontinuation of
clinical trial for reasons not related
to efficacy, safety, or feasibility.
BMJ. 2001;322:603–605.
5. Rosenthal R. The ‘‘file drawer
problem’’ and tolerance for null
results. Psychol Bull. 1979;86:638–
641.
6. Cochrane Methods Bias. Reporting
biases. Available at; http://methods.
cochrane.org/bias/reporting-biases.
Accessed 2016 June 21.
7. Higgins JPT, Green S. Cochrane
Handbook for systematic reviews of
interventions, version 5.1.0: includ-
ing unpublished studies in systematic





8. Hopewell S, McDonald S, Clarke M,
Egger M. Grey literature in meta-
analyses of randomized trials of health
care interventions. Cochrane Data-
base Syst Rev. 2007;2:MR000010.
9. ClinicalTrials.gov. Available at:
https://clinicaltrials.gov. Accessed
2016 June 21.
10. World Health Organization. Interna-
tional Clinical Trials Registry
Platform (ICTRP): Primary reg-
istries. Available at: http://www.
who.int/ictrp/network/primary/en/.
Accessed 2016 June 21.
11. BioMed Central. ISRCTN registry.
Available at: http://www.isrctn.com.
Accessed 2016 September 13.
12. Rifai N, Bossuyt PM, Ioannidis JP,
Bray KR, McShane LM, Golub RM,
Hooft L. Registering diagnostic and
prognostic trials of tests: Is it the
right thing to do? Clin Chem.
2014;60:1146–1152.
13. International Committee of Medical
Journal Editors. Clinical trial regis-





14. De Angelis C, Drazen JM, Frizelle
FA, Haug C, Hoey J, Horton R,
Kotzin S, Laine C, Marusic A,
Overbeke AJ, Schroeder TV, Sox
HC, Van Der Weyden MB, Interna-
tional Committee of Medical Journal
Editors. Clinical trial registration: A
statement from the International
Committee of Medical Journal Edi-
tors. N Engl J Med. 2004;351:1250–
1251.
123
Volume 475, Number 1, January 2017 Editorial 3
Editorial
